MedPath

Glucose Containing and Glucose Free Hemodialysate in Type 2 Diabetic Patients

Phase 4
Completed
Conditions
Type 2 Diabetes Mellitus
End-Stage Kidney Disease
Registration Number
NCT02009514
Lead Sponsor
Tampere University Hospital
Brief Summary

The purpose of this study is to investigate differences in glycemia

* during the whole hemodialysis day and the whole freeday

* during hemodialysis, during the evening and the night after hemodialysis and at the same time intervals during the freeday in an unselected type 2 diabetic patient group using both glucose-containing and glucose-free dialysate.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • type 2 diabetic patient
  • undergoing stable intermittent thrice weekly hemodialysis for at least one month
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Glucose below 4.0 mmol/lIn the end of a two week period

In the end of a two-week glucose-containing and glucose-free period percentage of hypoglycemic values of continuous glucose monitoring during the whole hemodialysis day is compared to the whole freeday. Similar comparison is made between the whole glucose-containing and the whole glucose-free hemodialysis day as well as between the whole glucose-containing and the whole glucose-free freeday.

Secondary Outcome Measures
NameTimeMethod
Glucose below 4.0 mmol/l during specified time intervalsIn the end of a two-week period

Percentage of hypoglycemia during the specified time intervals is compared within the glucose-containing and glucose-free hemodialysis day and freeday, and between the glucose-containing and glucose-free hemodialysis day and the freeday. Lastly comparisons are made between the glucose-containing and glucose-free hemodialysis day, and between the glucose-containing and glucose-free freeday.

© Copyright 2025. All Rights Reserved by MedPath